Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio
Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.
Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.
Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.
Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.
Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.